Information about Aerts Pharma
My details
*
*
*

Aerts Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0886.207.737

VAT liability
Yes
Established
27-12-2006
Last balance sheet year
2024
Company size
Small 1,6 FTE
Commercial name
APOTHEEK TACK
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Aerts Pharma

2024 2023 2022 2021
Profit/Loss 208,048 24 % 167,642 32 % 126,528 10 % 115,380
Equity 53,868 0 % 53,821 0 % 53,679 0 % 53,651
Gross margin 411,395 20 % 342,723 15 % 298,509 4 % 288,328
Employees 1.6 1.6 1.7 1.7

Publications from Aerts Pharma

Date Publication
23-06-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Goal - Resignations - Appointments (NL)
20-04-2009 Designation - Resignations - Appointments (NL)
16-01-2007 Constitution (NL)

Frequently asked questions

What is the VAT number of Aerts Pharma?
The VAT number of Aerts Pharma is BE 0886.207.737.
Wat is the PEPPOL ID of Aerts Pharma?
The PEPPOL ID of Aerts Pharma is 0208:0886207737. Log in or start a free trial to see the full overview.
When was Aerts Pharma founded?
Aerts Pharma was founded on 27-12-2006.
What is the address of Aerts Pharma?
The current registered office of Aerts Pharma is located at Zavelstraat 22, 3520 Zonhoven.
When was the last time Aerts Pharma filed their annual financial statements?
The most recent financial statements of Aerts Pharma were filed on 05-06-2025.
How many employees does Aerts Pharma have?
There are 1,6 FTEs working at Aerts Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Aerts Pharma?
At the time of its most recent financial statements, Aerts Pharma did not publish any turnover figures. Aerts Pharma reported a gross margin of €411,394.69.